Omeprazole/amoxicillin/rifabutin

{{Short description|Combination drug}}

{{Use American English|date=October 2021}}

{{Use dmy dates|date=October 2021}}

{{Infobox drug

| drug_name =

| type = combo

| image =

| width =

| alt =

| image2 =

| width2 =

| alt2 =

| caption =

| component1 = Omeprazole

| class1 = Proton-pump inhibitor

| component2 = Amoxicillin

| class2 = Penicillin-class antibacterial

| component3 = Rifabutin

| class3 = Rifamycin antibacterial

| tradename = Talicia

| Drugs.com = {{drugs.com|ppa|omeprazole-amoxicillin-and-rifabutin}}

| MedlinePlus =

| licence_CA =

| licence_EU =

| DailyMedID = Omeprazole_magnesium,_amoxicillin_and_rifabutin

| licence_US =

| pregnancy_AU =

| pregnancy_AU_comment =

| pregnancy_category=

| routes_of_administration = By mouth

| ATCvet =

| ATC_prefix = A02

| ATC_suffix = BD16

| ATC_supplemental =

| legal_AU =

| legal_AU_comment =

| legal_BR =

| legal_BR_comment =

| legal_CA =

| legal_CA_comment =

| legal_DE =

| legal_DE_comment =

| legal_NZ =

| legal_NZ_comment =

| legal_UK =

| legal_UK_comment =

| legal_US = Rx-only

| legal_US_comment = {{cite web | title=Talicia- omeprazole magnesium, amoxicillin and rifabutin capsule, delayed release | website=DailyMed | url=https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=68c4e9dc-dbcf-4151-b6f7-5e4b9922b76f | access-date=4 October 2021}}

| legal_EU =

| legal_EU_comment =

| legal_UN =

| legal_UN_comment =

| legal_status =

| CAS_number_Ref =

| CAS_number =

| CAS_supplemental =

| PubChem =

| IUPHAR_ligand =

| DrugBank_Ref =

| DrugBank =

| ChemSpiderID_Ref =

| ChemSpiderID =

| UNII_Ref =

| UNII =

| KEGG_Ref =

| KEGG = D11858

| ChEBI_Ref =

| ChEBI =

| ChEMBL_Ref =

| ChEMBL =

| NIAID_ChemDB =

| PDB_ligand =

| synonyms =

}}

Omeprazole/amoxicillin/rifabutin, sold under the brand name Talicia, is a fixed-dose combination medication used for the treatment of Helicobacter pylori infection. It is taken by mouth.

It was approved for medical use in the United States in November 2019.{{cite web | title=Drug Approval Package: Talicia | website=U.S. Food and Drug Administration (FDA) | date=9 April 2020 | url=https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/213004Orig1s000TOC.cfm | access-date=4 October 2021}}